Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 2—February 2024
Synopsis

Parechovirus A Circulation and Testing Capacities in Europe, 2015–2021

Laura BubbaComments to Author , Eeva K. Broberg, Thea K. Fischer, Peter Simmonds, Heli Harvala, and European Non-polio Enterovirus Network working group
Author affiliations: European Non-Polio Enterovirus Network, Geneva, Switzerland (L. Bubba); European Centre for Disease Prevention and Control, Solna, Sweden (E.K. Broberg); University Hospital of Nordsjaelland Department of Clinical Research, Hilleroed, Denmark (T.K. Fischer); University of Copenhagen Department of Public Health, Copenhagen, Denmark (T.K. Fischer); University of Oxford Nuffield Department of Medicine, Oxford, UK (P. Simmonds); National Health Service Blood and Transplant, London, UK (H. Harvala); University College London Division of Infection and Immunity, London (H. Harvala)

Main Article

Figure 1

Monthly distribution of parechovirus in Europe, overall and by country, 2015–2021. A) Overall monthly distribution. B) Monthly distribution for countries reporting >50 infections.

Figure 1. Monthly distribution of parechovirus in Europe, overall and by country, 2015–2021. A) Overall monthly distribution. B) Monthly distribution for countries reporting >50 infections.

Main Article

Page created: December 13, 2023
Page updated: January 25, 2024
Page reviewed: January 25, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external